| Resources |
|
| Government |
| Quick access to information based on government's structure
|
|
 |
|
|
Limited Coverage Drugs - Special Authority Criteria
| Generic Name / Strength / Form |
alendronate 10mg, 70mg alendronate plus cholecalciferol (vitamin D3) 70mg/5600 IU |
| Criteria |
Approval Period |
| Clinical or radiographically documented fracture due to osteoporosis
OR
Glucocorticoid-induced osteoporosis in patients who are receiving or expected to receive the equivalent dose of 7.5 mg of prednisone per day or greater AND for 90 consecutive days or longer. |
Indefinite
1 year |
Practitioner Exemptions
- No practitioner exemptions
Special Notes
- Clinical fracture is defined as a symptomatic (painful) fracture.
- Radiographically-documented fracture is defined as a fracture identified by X-ray (e.g., vertebral compression fracture). This may be asymptomatic.
- Coverage is intended for patients taking glucocorticoids with significant systemic absorption only (e.g., by oral or parenteral routes).
Online Forms (PDF 132K)
Click on the link to complete a Special Authority request form.
|
|
|